ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

ADVFN

Trade Now

EasyMarkets
Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P 500
4,585.59
(
0.8%
)
US Tech 100
15,612.00
(
1.36%
)
Dow Jones
36,117.38
(
0.17%
)
Brent Oil
75.615
(
1.31%
)
Bitcoin
43,364.91
(
0.15%
)
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Galmed Pharmaceuticals Ltd (GLMD)

  7. Galmed Pharmaceuticals Ltd (GLMD) Financials

GLMD Galmed Pharmaceuticals Ltd

0.42
0.025 (6.33%)
Dec 07 2023 - Closed
Delayed by 15 minutes

Galmed Pharmaceuticals Financial Summary

The current GLMD market cap is 705.6k. The company's latest EPS is USD -10.6345 and P/E is -0.04.

Income Statement

Annual Quarterly
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -5.38M-2.45M-2M-1.87M-1.47M
Net Income -5.35M-2.64M-1.83M-1.59M-1.47M
Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 2.04M0000
Operating Income -10.72M-22.38M-30.21M-32.88M-17.65M
Net Income -9.86M-20.46M-28.77M-32.47M-17.87M

Balance Sheet

Annual Quarterly
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 20.87M16.56M14.79M13.28M17.64M
Total Liabilities 5.12M3.14M2.8M2.72M2.09M
Total Equity 15.75M13.42M11.99M10.55M15.55M
Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 90.6M77.14M52.38M36.61M16.56M
Total Liabilities 2.71M7.29M8.23M6.11M3.14M
Total Equity 87.89M69.85M44.15M30.5M13.42M

Cash Flow

Annual Quarterly
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -14.48M-18.5M-1.7M-3.06M-5.24M
Investing 15.58M17.56M1.35M2.06M-1.48M
Financing 70k70k N/A N/A 6.19M
Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -9.02M-14.94M-26.29M-32.89M-18.5M
Investing -60.02M6.68M16.54M11.46M17.56M
Financing 80.18M143k768k17.37M70k

Stats and Ratios

Market Cap 705.6k
Price to Earnings Ratio -0.04
Price to Sales Ratio 0
Price to Cash Ratio 0.33
Price to Book Ratio 0.05
Dividend Yield -

Share Statistics

Shares Outstanding 1.68M
Average Volume (1 week) 104.71k
Average Volume (1 Month) 397.93k
52 Week Change -90.82%
52 Week High 14.175
52 Week Low 0.26
Spread (Intraday) 0.01 (3.33%)

Company Info

Company Name Galmed Pharmaceuticals Ltd
Address 16 tiomkin street
tel aviv, center 6578317
Website https://www.galmedpharma.com
Industry pharmaceutical preparations (2834)

Your Recent History

NASDAQ
GLMD
Galmed Pharmaceuticals
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com